Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Liver Cirrhosis

Free Subscription Articles published in Dig Dis Sci Retrieve available abstracts of 210 articles: HTML format

Single Articles

November 2024
1. LOYOLA-VELEZ AJ, John BV
   SGLT2 Inhibitors in Cirrhosis: A Promising Therapeutic Avenue with Potential Risks.
   Dig Dis Sci. 2024 Nov 24. doi: 10.1007/s10620-024-08703.
   PubMed    
   
   
   
2. VERMA M, Chan M, Toroghi S, Gallagher M, et al
   Multimedia-Based Education Led to Improvement in Disease Knowledge Among Patients with Cirrhosis.
   Dig Dis Sci. 2024 Nov 7. doi: 10.1007/s10620-024-08704.
   PubMed     Abstract available
   
   
   
3. GOYAL T, Song MW, Suresh D, Jasty VSJ, et al
   Serial Liver Stiffness Measurement and Fibrosis-4 Scores in Metabolic Dysfunction-Associated Steatotic Liver Disease.
   Dig Dis Sci. 2024;69:4250-4258.
   PubMed     Abstract available
   
   
   
4. JASTY VSJ, Urias E, Le Ashley Tiong K, Aboona MB, et al
   Prognostic Accuracy of Transient Elastography-Based Predictors in Diabetes and Obesity: A Multicenter International Cohort Study.
   Dig Dis Sci. 2024;69:4240-4249.
   PubMed     Abstract available
   
   
   October 2024
5. LIU ZW, Song T, Wang ZH, Sun LL, et al
   Predicting Portal Pressure Gradient in Patients with Decompensated Cirrhosis: A Non-invasive Deep Learning Model.
   Dig Dis Sci. 2024 Oct 28. doi: 10.1007/s10620-024-08701.
   PubMed     Abstract available
   
   
   
6. JINDAL A, Kumar G, Sharma MK, Vashishtha C, et al
   Derivation of Splenic Stiffness in Subjects with Normal Liver Stiffness and No Vascular Liver Disease Using Transient Elastography with a Spleen-Dedicated Module: A Large Cross Sectional Study.
   Dig Dis Sci. 2024;69:3942-3951.
   PubMed     Abstract available
   
   
   September 2024
7. PATEL KM, Zhang J, Marsden J, Bays C, et al
   Missed and Delayed Diagnoses of Chronic Liver Disease in Primary Care Patients with Cirrhosis.
   Dig Dis Sci. 2024 Sep 20. doi: 10.1007/s10620-024-08601.
   PubMed     Abstract available
   
   
   
8. SOLANO QP, Chen X, Parikh ND, Tapper EB, et al
   Racial and Ethnic Disparities in Outcomes After the Development of Ascites: A National Cohort Study.
   Dig Dis Sci. 2024;69:3214-3219.
   PubMed     Abstract available
   
   
   August 2024
9. DIAZ PM, Saly DL, Horick N, Petrosyan R, et al
   Prognosis of Transplant-Ineligible Patients with Cirrhosis and Acute Kidney Injury Who Initiate Renal Replacement Therapy.
   Dig Dis Sci. 2024 Aug 31. doi: 10.1007/s10620-024-08623.
   PubMed     Abstract available
   
   
   
10. HU Y, Zhou M, Liu D, Gong J, et al
    Risk Factors for Rebleeding After Endoscopic Injection of Cyanoacrylate Glue for Gastric Varices: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2024;69:2890-2903.
    PubMed     Abstract available
    
    
    July 2024
11. IFRAH A, Fromer R, Gayner AH, Yeung HM, et al
    Discharge Outcomes of Hospitalized Patients with New Onset Decompensated Cirrhosis.
    Dig Dis Sci. 2024 Jul 31. doi: 10.1007/s10620-024-08574.
    PubMed     Abstract available
    
    
    
12. EDELSON JC, Rockey DC
    Safety of Endoscopy in Cirrhosis.
    Dig Dis Sci. 2024 Jul 8. doi: 10.1007/s10620-024-08539.
    PubMed     Abstract available
    
    
    
13. CHANG CW, Hsu WF, Tseng KC, Chen CY, et al
    Benefits of Hepatitis C Viral Eradication: A Real-World Nationwide Cohort Study in Taiwan.
    Dig Dis Sci. 2024 Jul 4. doi: 10.1007/s10620-024-08512.
    PubMed     Abstract available
    
    
    
14. STERN C, Ngo A, Villela-Nogueira C, Thabut D, et al
    A Simple and Reliable 2D-Shear Wave Elastography and UltraSound Coefficient Attenuation Parameter Technique in Chronic Liver Diseases.
    Dig Dis Sci. 2024;69:2648-2654.
    PubMed     Abstract available
    
    
    June 2024
15. BROWN C, Hernandez R, Ford T, Aksan N, et al
    Inadequate Dietary Education and Poor Adherence to a High Protein, Low Sodium Diet in Cirrhosis: Mixed Methods Approach.
    Dig Dis Sci. 2024 Jun 28. doi: 10.1007/s10620-024-08526.
    PubMed     Abstract available
    
    
    
16. FULLER SR, Schreiner AD
    Hepatic Fibrosis Risk Assessment in Primary Care: Opportunities and Challenges.
    Dig Dis Sci. 2024 Jun 6. doi: 10.1007/s10620-024-08498.
    PubMed    
    
    
    May 2024
17. KOCH DG, Rockey DC, Litwin SS, Tedford RJ, et al
    H2FPEF Scores Are Increased in Patients with NASH Cirrhosis and Are Associated with Post-liver Transplant Heart Failure.
    Dig Dis Sci. 2024 May 23. doi: 10.1007/s10620-024-08438.
    PubMed     Abstract available
    
    
    
18. PEMMASANI G, Tremaine W, Karagozian R, John S, et al
    Impact of Cirrhosis Etiology on the Risk for Venous Thromboembolism.
    Dig Dis Sci. 2024 May 3. doi: 10.1007/s10620-024-08440.
    PubMed     Abstract available
    
    
    
19. THRIFT AP, Nguyen Wenker TH, Godwin K, Balakrishnan M, et al
    An Electronic Health Record Model for Predicting Risk of Hepatic Fibrosis in Primary Care Patients.
    Dig Dis Sci. 2024 May 3. doi: 10.1007/s10620-024-08437.
    PubMed     Abstract available
    
    
    April 2024
20. HSIEH HC, Chang WP, Huang PJ, Wang CH, et al
    Effectiveness of Exercise Interventions on Body Composition, Exercise Capacity, Fatigue, and Quality of Life in Patients with Liver Cirrhosis: A Meta-Analysis of Randomized Controlled Trials.
    Dig Dis Sci. 2024 Apr 24. doi: 10.1007/s10620-024-08447.
    PubMed     Abstract available
    
    
    
21. LEE DU, Bhowmick K, Kolachana S, Schuster K, et al
    Inpatient Cost Burdens of Treating Chronic Hepatitis B in US Hospitals: A Weighted Analysis of a National Database.
    Dig Dis Sci. 2024 Apr 24. doi: 10.1007/s10620-024-08448.
    PubMed     Abstract available
    
    
    
22. HORBAL SR, Belancourt PX, Zhang P, Holcombe SA, et al
    Independent Associations of Aortic Calcification with Cirrhosis and Liver Related Mortality in Veterans with Chronic Liver Disease.
    Dig Dis Sci. 2024 Apr 23. doi: 10.1007/s10620-024-08450.
    PubMed     Abstract available
    
    
    
23. MANNING ME, Fricker Z
    Cardiopulmonary Resuscitation Outcomes and Trainee Perception of Code Status Discussions in Patients with Cirrhosis.
    Dig Dis Sci. 2024 Apr 23. doi: 10.1007/s10620-024-08443.
    PubMed     Abstract available
    
    
    
24. WEBER S, Unger K, Alunni-Fabbroni M, Hirner-Eppeneder H, et al
    Metabolomic Analysis of Human Cirrhosis and Hepatocellular Carcinoma: A Pilot Study.
    Dig Dis Sci. 2024 Apr 23. doi: 10.1007/s10620-024-08446.
    PubMed     Abstract available
    
    
    
25. CHANG ML, Le PH, Chen WT, Chen TD, et al
    Hepatic and Extrahepatic Characteristics of Autoimmune Hepatitis: A 23-year Hospital-Based Cohort Study.
    Dig Dis Sci. 2024 Apr 23. doi: 10.1007/s10620-024-08439.
    PubMed     Abstract available
    
    
    
26. MOON AM, Swier RM, Lane LM, Barritt AS 4th, et al
    Statewide Survey of Primary Care and Subspecialty Providers on Hepatocellular Carcinoma Risk-Stratification and Surveillance Practices.
    Dig Dis Sci. 2024 Apr 23. doi: 10.1007/s10620-024-08442.
    PubMed     Abstract available
    
    
    
27. MCCURDY H, Nobbe A, Scott D, Patton H, et al
    Organizational and Implementation Factors Associated with Cirrhosis Care in the Veterans Health Administration.
    Dig Dis Sci. 2024 Apr 14. doi: 10.1007/s10620-024-08409.
    PubMed     Abstract available
    
    
    
28. PEARLMAN BL
    Direct-Acting Antiviral Therapy for Patients with Chronic Hepatitis C Infection and Decompensated Cirrhosis.
    Dig Dis Sci. 2024 Apr 5. doi: 10.1007/s10620-024-08393.
    PubMed     Abstract available
    
    
    
29. KHAMSEH ME, Malek M, Jahangiri S, Nobarani S, et al
    Insulin Resistance/Sensitivity Measures as Screening Indicators of Metabolic-Associated Fatty Liver Disease and Liver Fibrosis.
    Dig Dis Sci. 2024;69:1430-1443.
    PubMed     Abstract available
    
    
    
30. WILLIAMS EE, Mladenovic A, Ranginani D, Weber R, et al
    Role of Spleen Stiffness Measurement in the Evaluation of Metabolic Dysfunction-Associated Steatotic Liver Disease.
    Dig Dis Sci. 2024;69:1444-1453.
    PubMed     Abstract available
    
    
    
31. BEHARI J
    Spleen Stiffness Measurement in Metabolic Dysfunction-Associated Steatotic Liver Disease-Value Added or Work in Progress?
    Dig Dis Sci. 2024;69:1093-1095.
    PubMed    
    
    
    March 2024
32. ARSHAD T, Vainer D, Khan H, Baral A, et al
    Development of Clinical Algorithm Utilizing Vibration-Controlled Transient Elastography to Detect Advanced Hepatic Fibrosis in Liver Transplant Recipients.
    Dig Dis Sci. 2024 Mar 18. doi: 10.1007/s10620-024-08366.
    PubMed     Abstract available
    
    
    
33. KAHN-BOESEL O, Mitchell H, Li L, Zhu E, et al
    Hospital-Level Care at Home for Patients with Cirrhosis.
    Dig Dis Sci. 2024 Mar 11. doi: 10.1007/s10620-024-08361.
    PubMed     Abstract available
    
    
    
34. PETROSYAN R, Endres P, Ufere NN, St Hillien SA, et al
    Healthcare Resource Utilization and Goals of Care Discussions in Patients with Cirrhosis and Acute Kidney Injury.
    Dig Dis Sci. 2024 Mar 7. doi: 10.1007/s10620-024-08317.
    PubMed     Abstract available
    
    
    
35. PATEL AA, Walling A, Bansal A
    A New Look at Goals-of-Care Discussions in Patients with Cirrhosis and Acute Kidney Injury.
    Dig Dis Sci. 2024 Mar 7. doi: 10.1007/s10620-024-08300.
    PubMed    
    
    
    
36. VASSILOPOULOS A, Kalligeros M, Vassilopoulos S, Shehadeh F, et al
    Prevalence of Steatotic Liver Disease Among US Adults with Rheumatoid Arthritis.
    Dig Dis Sci. 2024;69:989-1003.
    PubMed     Abstract available
    
    
    February 2024
37. KALAITZAKIS ZE, Giahnakis E, Koutroubakis IE, Mouzas IA, et al
    Bariatric Nutritional Intervention in Obese Patients with Compensated Liver Cirrhosis: A Four-Year Prospective Study.
    Dig Dis Sci. 2024 Feb 27. doi: 10.1007/s10620-023-08223.
    PubMed     Abstract available
    
    
    
38. CON D, Tu S, Clayton-Chubb D, Lubel JS, et al
    Effect of Concurrent Metabolic Dysfunction-Associated Steatotic Liver Disease on Serial Non-invasive Fibrosis Markers in Chronic Hepatitis B.
    Dig Dis Sci. 2024 Feb 20. doi: 10.1007/s10620-024-08354.
    PubMed     Abstract available
    
    
    
39. MUKUND A, Aravind A, Jindal A, Tevethia HV, et al
    Predictors and Outcomes of Post-transjugular Intrahepatic Portosystemic Shunt Liver Failure in Patients with Cirrhosis.
    Dig Dis Sci. 2024 Feb 10. doi: 10.1007/s10620-023-08256.
    PubMed     Abstract available
    
    
    
40. LI R, Sarin S
    Disparity Among African Americans in Transjugular Intrahepatic Portosystemic Shunt Procedure: A National Inpatient Sample Analysis from 2015 to 2020.
    Dig Dis Sci. 2024 Feb 6. doi: 10.1007/s10620-024-08273.
    PubMed     Abstract available
    
    
    
41. ZEREM E, Denjagic Basic M, Kurtcehajic A, Zerem D, et al
    Indications for the Use of Endoscopic Ultrasound-Guided Liver Biopsy in Patients with Liver Fibrosis.
    Dig Dis Sci. 2024;69:643-644.
    PubMed    
    
    
    
42. BEHARI J, Bradley A, Townsend K, Becich MJ, et al
    Limitations of Noninvasive Tests-Based Population-Level Risk Stratification Strategy for Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2024;69:370-383.
    PubMed     Abstract available
    
    
    January 2024
43. ASADA S, Namisaki T, Kaji K, Takaya H, et al
    VWF/ADAMTS13 Ratio as a Potential Predictive Biomarker for Acute Kidney Injury Onset in Cirrhosis.
    Dig Dis Sci. 2024 Jan 20. doi: 10.1007/s10620-023-08257.
    PubMed     Abstract available
    
    
    
44. BOWMAN CA, Bichoupan K, Posner S, Schonfeld E, et al
    A Prospective Open-Label Dose-Response Study to Correct Vitamin D Deficiency in Cirrhosis.
    Dig Dis Sci. 2024 Jan 13. doi: 10.1007/s10620-023-08224.
    PubMed     Abstract available
    
    
    
45. TSAI SY, O'Leary JG
    Optimizing Outcomes in Patients with Ascites Complicating Cirrhosis-Maximizing the Hour of Power.
    Dig Dis Sci. 2024 Jan 13. doi: 10.1007/s10620-023-08255.
    PubMed    
    
    
    
46. BADAL J, Badal B, Nawras M, Lee-Smith W, et al
    Diagnostic Paracentesis Within 1 Day Is Associated With Reduced Mortality and Length of Hospital Stay in Patients with Cirrhosis and Ascites.
    Dig Dis Sci. 2024 Jan 13. doi: 10.1007/s10620-023-08249.
    PubMed     Abstract available
    
    
    
47. BLOOM PP, Che Z, Hyde A, Johnson E, et al
    Development and Evaluation of a Patient Cirrhosis Knowledge Assessment.
    Dig Dis Sci. 2024 Jan 3. doi: 10.1007/s10620-023-08238.
    PubMed     Abstract available
    
    
    December 2023
48. JAMES M, Alazawi W
    Non-invasive Tests of Fibrosis: Does One Size Fit All?
    Dig Dis Sci. 2023;68:4285-4286.
    PubMed    
    
    
    
49. ARORA U, Goyal RM, Teh KKJ, Pei Y, et al
    Poor Performance of Non-invasive Tests for Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: A Multicentric Asian Study.
    Dig Dis Sci. 2023;68:4485-4498.
    PubMed     Abstract available
    
    
    November 2023
50. SUN Y, Lu M, Feldman R, Saul M, et al
    Positive Predictive Value of Cirrhosis and Chronic Pancreatitis Diagnoses in Individuals with Alcohol Use Disorder: A Single-Center Study.
    Dig Dis Sci. 2023 Nov 29. doi: 10.1007/s10620-023-08183.
    PubMed     Abstract available
    
    
    
51. WONG ZY, Koh JH, Muthiah M, Koh B, et al
    Proton Pump Inhibitors Increases Longitudinal Risk of Mortality, Decompensation, and Infection in Cirrhosis: A Meta-Analysis.
    Dig Dis Sci. 2023 Nov 15. doi: 10.1007/s10620-023-08150.
    PubMed     Abstract available
    
    
    
52. LOW EXS, Wang YP, Lu CL
    Risks of Proton Pump Inhibitors in Patients with Cirrhosis: Please Peruse the Indications.
    Dig Dis Sci. 2023 Nov 15. doi: 10.1007/s10620-023-08153.
    PubMed     Abstract available
    
    
    October 2023
53. JINDAL A, Sharma MK, Vijayaraghavan R, Sm S, et al
    Severity of Acute Portal Hypertension Determines the Clinical Outcomes in Severe Alcoholic Hepatitis.
    Dig Dis Sci. 2023 Oct 31. doi: 10.1007/s10620-023-08144.
    PubMed     Abstract available
    
    
    
54. GONZALEZ HC, Trudeau S
    COVID-19 + Cirrhosis = Excess Hospital Confinement, Excess Casualties.
    Dig Dis Sci. 2023 Oct 21. doi: 10.1007/s10620-023-08106.
    PubMed    
    
    
    
55. TWOHIG PA, Scholten K, Schissel M, Brittan K, et al
    Mortality Increased Among Hospitalized Patients with Cirrhosis Before and Following Different Waves of the COVID-19 Pandemic.
    Dig Dis Sci. 2023 Oct 21. doi: 10.1007/s10620-023-08105.
    PubMed     Abstract available
    
    
    
56. BANGARU S, Sundaresh R, Lee A, Prause N, et al
    Predictive Algorithm for Hepatic Steatosis Detection Using Elastography Data in the Veterans Affairs Electronic Health Records.
    Dig Dis Sci. 2023 Oct 21. doi: 10.1007/s10620-023-08043.
    PubMed     Abstract available
    
    
    
57. BUI HH, Nguyen ST, Phan ST, Nguyen KM, et al
    Evaluating M2BPGi as a Marker for Liver Fibrosis in Patients with Chronic Hepatitis B.
    Dig Dis Sci. 2023 Oct 20. doi: 10.1007/s10620-023-08143.
    PubMed     Abstract available
    
    
    
58. LI R, Li M, Bidulescu A, Fly AD, et al
    Diets with Higher Anti-inflammatory Potential Associated with Lower Risk of Development of Nonalcoholic Fatty Liver Disease and Early-Stage of Fibrosis Among US Adults.
    Dig Dis Sci. 2023;68:4009-4021.
    PubMed     Abstract available
    
    
    September 2023
59. GOBLE S, Akambase J, Prieto J, Balderramo D, et al
    MBOAT7 rs641738 Variant Is Not Associated with an Increased Risk of Hepatocellular Carcinoma in a Latin American Cohort.
    Dig Dis Sci. 2023 Sep 8. doi: 10.1007/s10620-023-08104.
    PubMed     Abstract available
    
    
    
60. CHOI AY, Li X, Guo W, Chandan VS, et al
    Performance of Endoscopic Ultrasound-Guided Versus Percutaneous Liver Biopsy in Diagnosing Stage 3-4 Fibrosis.
    Dig Dis Sci. 2023;68:3774-3780.
    PubMed     Abstract available
    
    
    
61. MCNALLY BB, Rangan P, Wijarnpreecha K, Fallon MB, et al
    Fibrosis-4 Index Score Predicts Concomitant Coronary Artery Diseases Across the Spectrum of Fatty Liver Disease.
    Dig Dis Sci. 2023;68:3765-3773.
    PubMed     Abstract available
    
    
    July 2023
62. TAPPER EB, Saleh ZM, Lizza S, Chen X, et al
    CAREGIVER Randomized Trial of Two Mindfulness Methods to Improve the Burden and Distress of Caring for Persons with Cirrhosis.
    Dig Dis Sci. 2023 Jul 27. doi: 10.1007/s10620-023-08042.
    PubMed     Abstract available
    
    
    
63. SUAREZ M, Martinez R, Torres AM, Torres B, et al
    A Machine Learning Method to Identify the Risk Factors for Liver Fibrosis Progression in Nonalcoholic Steatohepatitis.
    Dig Dis Sci. 2023 Jul 21. doi: 10.1007/s10620-023-08031.
    PubMed     Abstract available
    
    
    
64. MOORE JA, Wheless WH, Zhang J, Marsden J, et al
    Gaps in Confirmatory Fibrosis Risk Assessment in Primary Care Patients with Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2023;68:2946-2953.
    PubMed     Abstract available
    
    
    
65. BROWN C, Aksan N, Chang P, Jagannathan P, et al
    Delayed Diagnostic Paracentesis Is Associated with Increased Preventable Healthcare Utilization in Disadvantaged Patient Populations with Advanced Liver Disease and Elevated INR.
    Dig Dis Sci. 2023;68:2954-2962.
    PubMed     Abstract available
    
    
    June 2023
66. WENTWORTH BJ, Khot R, Caldwell SH
    The Many Faces of Primary Sclerosing Cholangitis: Controversy Abounds.
    Dig Dis Sci. 2023 Jun 26. doi: 10.1007/s10620-023-08003.
    PubMed     Abstract available
    
    
    
67. ATTANASI ML, Bou Daher H, Rockey DC
    Natural History and Outcomes of Cavernous Transformation of the Portal Vein in Cirrhosis.
    Dig Dis Sci. 2023 Jun 22. doi: 10.1007/s10620-023-07993.
    PubMed     Abstract available
    
    
    
68. MCHENRY S, Awad A, Kozlitina J, Stitziel NO, et al
    Low LDL Cholesterol Is Not an Independent Risk Factor for Hepatic Steatosis.
    Dig Dis Sci. 2023 Jun 8. doi: 10.1007/s10620-023-07980.
    PubMed     Abstract available
    
    
    
69. BOU DAHER H, Manka P, Syn WK
    Settling the Score: Which Fibrosis Screening Tool Is the Most Reliable for Nonalcoholic Fatty Liver Disease?
    Dig Dis Sci. 2023;68:2217-2220.
    PubMed    
    
    
    
70. BERTOT LC, Jeffrey GP, de Boer B, Wang Z, et al
    Comparative Accuracy of Clinical Fibrosis Markers, Hepascore and Fibroscan(R) to Detect Advanced Fibrosis in Patients with Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2023;68:2757-2767.
    PubMed     Abstract available
    
    
    May 2023
71. MUNOZ AE, Pollarsky F, Marino M, Cartier M, et al
    Baseline Severity and Inflammation Would Influence the Effect of Simvastatin on Clinical Outcomes in Cirrhosis Patients.
    Dig Dis Sci. 2023 May 22. doi: 10.1007/s10620-023-07969.
    PubMed     Abstract available
    
    
    
72. KAPLAN DE
    Statins in Cirrhosis: Trial Data Are in but the Jury Is Still Out.
    Dig Dis Sci. 2023 May 22. doi: 10.1007/s10620-023-07970.
    PubMed    
    
    
    
73. MUKUND A, Marri UK, Jindal A, Choudhury A, et al
    Safety and Efficacy of Transjugular Intrahepatic Portosystemic Shunt for Non-tumoral Cirrhotic Portal Vein Thrombosis Not Responding to Anticoagulation Therapy.
    Dig Dis Sci. 2023 May 12. doi: 10.1007/s10620-023-07930.
    PubMed     Abstract available
    
    
    
74. SANDHU S, John BV
    Spontaneous Bacterial Peritonitis: The Bug Matters.
    Dig Dis Sci. 2023;68:1667-1669.
    PubMed    
    
    
    
75. FUREY C, Zhou S, Park JH, Foong A, et al
    Impact of Bacteria Types on the Clinical Outcomes of Spontaneous Bacterial Peritonitis.
    Dig Dis Sci. 2023;68:2140-2148.
    PubMed     Abstract available
    
    
    April 2023
76. CHOW KW, Ibrahim BM, Yum JJ, Dang A, et al
    Barriers to Lactulose Adherence in Patients with Cirrhosis and Hepatic Encephalopathy.
    Dig Dis Sci. 2023 Apr 29. doi: 10.1007/s10620-023-07935.
    PubMed     Abstract available
    
    
    
77. GARG R, Mohammed A, Singh A, Siddiki H, et al
    Mortality Trends, Outcomes, and Predictors of Portal Vein Thrombosis in Acute Pancreatitis Patients: A Propensity-Matched National Study.
    Dig Dis Sci. 2023 Apr 25. doi: 10.1007/s10620-023-07945.
    PubMed     Abstract available
    
    
    
78. WANG CL, Huang CH, Wu VC, Wu CL, et al
    Prognostic Effects of Liver Fibrosis and Steatosis Determined Using Transient Elastography in Patients with Chronic Hepatitis B or C.
    Dig Dis Sci. 2023 Apr 18. doi: 10.1007/s10620-023-07943.
    PubMed     Abstract available
    
    
    
79. PATERNOSTRO R
    Muscle Mass Effect: The Importance of Diagnosing and Treating Sarcopenia in Patients with Advanced Chronic Liver Disease.
    Dig Dis Sci. 2023;68:1089-1090.
    PubMed    
    
    
    
80. UNALP-ARIDA A, Ruhl CE
    Prepandemic Prevalence Estimates of Fatty Liver Disease and Fibrosis Defined by Liver Elastography in the United States.
    Dig Dis Sci. 2023;68:1237-1252.
    PubMed     Abstract available
    
    
    
81. MAHMUD N, Reddy KR, Taddei TH, Kaplan DE, et al
    Type of Infection Is Associated with Prognosis in Acute-on-Chronic Liver Failure: A National Veterans Health Administration Study.
    Dig Dis Sci. 2023;68:1632-1640.
    PubMed     Abstract available
    
    
    March 2023
82. PROTOPAPAS AA, Savopoulos C, Skoura L, Goulis I, et al
    Anticoagulation in Patients with Liver Cirrhosis: Friend or Foe?
    Dig Dis Sci. 2023 Mar 24. doi: 10.1007/s10620-023-07858.
    PubMed     Abstract available
    
    
    
83. SMITH HT, de Souza AR, Thompson AH, McLaughlin MM, et al
    Cholestatic Pruritus Treatments in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: A Systematic Literature Review.
    Dig Dis Sci. 2023 Mar 18:1-21. doi: 10.1007/s10620-023-07862.
    PubMed     Abstract available
    
    
    
84. KHALIFA A, Obeid JS, Gregoski MJ, Rockey DC, et al
    Accurate Identification of Patients with Cirrhosis and Its Complications in the Electronic Health Record.
    Dig Dis Sci. 2023 Mar 10. doi: 10.1007/s10620-023-07876.
    PubMed     Abstract available
    
    
    
85. CALMET FH, Martin P
    Acid Test: MELD-Lactate Enhances Prediction in Patients with Variceal Hemorrhage.
    Dig Dis Sci. 2023;68:723-724.
    PubMed    
    
    
    
86. SINGAL AG, Parikh ND, Hoshida Y
    Precision HCC Surveillance: It Is All in the Number (Needed).
    Dig Dis Sci. 2023;68:720-722.
    PubMed    
    
    
    
87. AGGARWAL M, Garg R, Parthasarthy G, Nowacki AS, et al
    Crohn's Disease Is Associated with Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2023;68:1006-1015.
    PubMed     Abstract available
    
    
    
88. ELHENCE A, Anand A, Biswas S, Vaishnav M, et al
    Compensated Advanced Chronic Liver Disease in Nonalcoholic Fatty Liver Disease: Two-Step Strategy is Better than Baveno Criteria.
    Dig Dis Sci. 2023;68:1016-1025.
    PubMed     Abstract available
    
    
    February 2023
89. DUKEWICH M, Liu CH, Weinberg EM, Mahmud N, et al
    Clinical Predictors of Intensive Care Unit Transfer in Admitted Patients with Cirrhosis.
    Dig Dis Sci. 2023 Feb 12. doi: 10.1007/s10620-023-07856.
    PubMed     Abstract available
    
    
    
90. ISLAM KB, Brandman D, Chu JN, Goldman ML, et al
    Primary Care Providers and Nonalcoholic Fatty Liver Disease: A Needs Assessment Survey.
    Dig Dis Sci. 2023;68:434-438.
    PubMed     Abstract available
    
    
    
91. LV L, Wang D, Yin J, Yang T, et al
    Downregulation of miR-20b-5p Contributes to the Progression of Liver Fibrosis via the STAT3 Signaling Pathway In Vivo and In Vitro.
    Dig Dis Sci. 2023;68:487-496.
    PubMed     Abstract available
    
    
    January 2023
92. SONG J, Wang X, Yan Y, Xiang T, et al
    MELD 3.0 Score for Predicting Survival in Patients with Cirrhosis After Transjugular Intrahepatic Portosystemic Shunt Creation.
    Dig Dis Sci. 2023 Jan 30. doi: 10.1007/s10620-023-07834.
    PubMed     Abstract available
    
    
    
93. DAHMUS J, Hummer B, Rivas G, Schmitz K, et al
    Patients with Nonalcoholic Steatohepatitis and Advanced Liver Disease Have the Lowest Cardiorespiratory Fitness.
    Dig Dis Sci. 2023 Jan 24. doi: 10.1007/s10620-022-07809.
    PubMed     Abstract available
    
    
    December 2022
94. LI T, Liu J, Zhao J, Bai Y, et al
    Sarcopenia Defined by Psoas Muscle Thickness Predicts Mortality After Transjugular Intrahepatic Portosystemic Shunt.
    Dig Dis Sci. 2022 Dec 30. doi: 10.1007/s10620-022-07806.
    PubMed     Abstract available
    
    
    
95. RUDNICK SR, Ugwuegbu J, Soufleris SJ, Bundy R, et al
    Telephone-Only Visits Preserved Hepatocellular Cancer Screening Rates in Patients with Cirrhosis Early in the COVID-19 Pandemic.
    Dig Dis Sci. 2022 Dec 23. doi: 10.1007/s10620-022-07786.
    PubMed     Abstract available
    
    
    
96. JINDAL A, Agarwal S, Sharma S, Kumar M, et al
    Assessment of the Performance of Non-invasive Criteria for the Evaluation of Clinically Significant Portal Hypertension in Patients with Compensated Advanced Chronic Liver Disease.
    Dig Dis Sci. 2022 Dec 23. doi: 10.1007/s10620-022-07778.
    PubMed     Abstract available
    
    
    
97. WANG ZJ, Lv XH, Yang JL
    Methodological Issues to Be Considered in Evaluating Advanced Endoscopic Resection Techniques in Cirrhosis.
    Dig Dis Sci. 2022 Dec 20. doi: 10.1007/s10620-022-07767.
    PubMed    
    
    
    
98. TAHATA Y, Sakamori R, Yamada R, Kodama T, et al
    Improved Liver Function After Sustained Virologic Response Enhanced Prognosis in Hepatitis C with Compensated Advanced Liver Fibrosis.
    Dig Dis Sci. 2022 Dec 16. doi: 10.1007/s10620-022-07629.
    PubMed     Abstract available
    
    
    November 2022
99. HORVATITS T, Mahmud N, Serper M, Seiz O, et al
    MELD-Lactate Predicts Poor Outcome in Variceal Bleeding in Cirrhosis.
    Dig Dis Sci. 2022 Nov 14. pii: 10.1007/s10620-022-07744.
    PubMed     Abstract available
    
    
    
100. CURRAN C, Priest M, Datta S, Forrest EH, et al
     Hepatocellular Carcinoma Risk Scores Predict Patients Under Surveillance at Low Risk of Benefit and High Risk of Harm.
     Dig Dis Sci. 2022 Nov 14. pii: 10.1007/s10620-022-07731.
     PubMed     Abstract available
     
     
     
101. TAPPER EB, Zhao Z, Mazumder N, Parikh ND, et al
     Incidence of, Risk Factors for, and Outcomes After Ascites in a Population-Based Cohort of Older Americans.
     Dig Dis Sci. 2022;67:5327-5335.
     PubMed     Abstract available
     
     
     
102. CARDOSO AC, Tovo CV, Leite NC, El Bacha IA, et al
     Validation and Performance of FibroScan(R)-AST (FAST) Score on a Brazilian Population with Nonalcoholic Fatty Liver Disease.
     Dig Dis Sci. 2022;67:5272-5279.
     PubMed     Abstract available
     
     
     October 2022
103. LIU CH, Jiang W, Wu DB, Zeng QM, et al
     Concomitant Diseases and Co-contribution on Progression of Liver Stiffness in Patients with Hepatitis B Virus Infection.
     Dig Dis Sci. 2022 Oct 13. pii: 10.1007/s10620-022-07695.
     PubMed     Abstract available
     
     
     September 2022
104. KHAKOO NS, Sultan S, Reynolds JM, Levy C, et al
     Efficacy and Safety of Bezafibrate Alone or in Combination with Ursodeoxycholic Acid in Primary Biliary Cholangitis: Systematic Review and Meta-Analysis.
     Dig Dis Sci. 2022 Sep 30. pii: 10.1007/s10620-022-07704.
     PubMed     Abstract available
     
     
     
105. SINGH A, De A, Singh MP, Rathi S, et al
     Antibody Response and Safety of ChAdOx1-nCOV (Covishield) in Patients with Cirrhosis: A Cross-Sectional, Observational Study.
     Dig Dis Sci. 2022 Sep 25. pii: 10.1007/s10620-022-07641.
     PubMed     Abstract available
     
     
     
106. LIU BD, Qureshi K
     Secondary Treatment of Primary Biliary Cholangitis: Early Prediction of Inadequate Response to Ursodeoxycholic Acid in Patients with PBC.
     Dig Dis Sci. 2022 Sep 13. pii: 10.1007/s10620-022-07661.
     PubMed    
     
     
     
107. CHAPIN SE, Goldberg DS, Kaplan DE, Mahmud N, et al
     External Validation of the FIPS Score for Post-TIPS Mortality in a National Veterans Affairs Cohort.
     Dig Dis Sci. 2022;67:4581-4589.
     PubMed     Abstract available
     
     
     August 2022
108. AMES PRJ, D'Andrea G, Arcaro A, Marottoli V, et al
     Liver Cirrhosis Patients Homozygous for MTHFR C677T Develop Portal Vein Thrombosis 8 Years Earlier Than Wild Type.
     Dig Dis Sci. 2022 Aug 24. pii: 10.1007/s10620-022-07666.
     PubMed     Abstract available
     
     
     
109. CANCADO GGL, Couto CA, Terrabuio DRB, Cancado ELR, et al
     Response to Ursodeoxycholic Acid May Be Assessed Earlier to Allow Second-Line Therapy in Patients with Unresponsive Primary Biliary Cholangitis.
     Dig Dis Sci. 2022 Aug 22. pii: 10.1007/s10620-022-07654.
     PubMed     Abstract available
     
     
     
110. PREMKUMAR M, Mehtani R, Kulkarni AV, Duseja AK, et al
     Association of Heparin-Like Effect, Factor VII/XIII Deficiency and Fibrinolysis with Rebleeding Risk in Cirrhosis with Acute Variceal Bleeding.
     Dig Dis Sci. 2022 Aug 19. pii: 10.1007/s10620-022-07656.
     PubMed     Abstract available
     
     
     
111. FERREIRA RD, John BV
     Viral Vector Vaccines Are Victorious Against COVID-19 in Patients with Cirrhosis.
     Dig Dis Sci. 2022 Aug 10. pii: 10.1007/s10620-022-07644.
     PubMed    
     
     
     July 2022
112. LIU YC, Cheng YT, Chen YC, Hsieh YC, et al
     Comparing Predictability of Non-invasive Tools for Hepatocellular Carcinoma in Treated Chronic Hepatitis C Patients Characters: 102 (< 120).
     Dig Dis Sci. 2022 Jul 27. pii: 10.1007/s10620-022-07621.
     PubMed     Abstract available
     
     
     
113. MANDORFER M
     Individualization of HCC and Portal Hypertension Surveillance in Patients with Compensated Advanced Chronic Liver Disease and SVR.
     Dig Dis Sci. 2022 Jul 27. pii: 10.1007/s10620-022-07623.
     PubMed    
     
     
     
114. ADAMS PC
     Hepatocellular Carcinoma in Hemochromatosis: Where or When?
     Dig Dis Sci. 2022 Jul 11. pii: 10.1007/s10620-022-07609.
     PubMed    
     
     
     
115. IZZY M, VanWagner LB
     Analyzing the Different Prevalence for Cirrhotic Cardiomyopathy in Different Studies.
     Dig Dis Sci. 2022 Jul 5. pii: 10.1007/s10620-022-07580.
     PubMed    
     
     
     
116. YARRA P, Dunn W, Younossi Z, Kuo YF, et al
     Association of Previous Gastric Bypass Surgery and Patient Outcomes in Alcohol-Associated Cirrhosis Hospitalizations.
     Dig Dis Sci. 2022 Jul 4. pii: 10.1007/s10620-022-07591.
     PubMed     Abstract available
     
     
     
117. ELFEKI MA, Robles J, Akhtar Z, Ullah F, et al
     Impact of Fibrosis-4 Index Prior to COVID-19 on Outcomes in Patients at Risk of Non-alcoholic Fatty Liver Disease.
     Dig Dis Sci. 2022;67:3333-3339.
     PubMed     Abstract available
     
     
     June 2022
118. VIJAYARAGHAVAN R, Sarin SK, Bharadwaj A, Anand L, et al
     Intragastric Balloon in Obese Compensated Nonalcoholic Steatohepatitis Cirrhosis Patients Is Safe and Achieves Significant Weight Reduction at 6-Months.
     Dig Dis Sci. 2022 Jun 28. pii: 10.1007/s10620-022-07596.
     PubMed     Abstract available
     
     
     
119. MAYO MJ, Carey E, Smith HT, Mospan AR, et al
     Impact of Pruritus on Quality of Life and Current Treatment Patterns in Patients with Primary Biliary Cholangitis.
     Dig Dis Sci. 2022 Jun 15. pii: 10.1007/s10620-022-07581.
     PubMed     Abstract available
     
     
     
120. KUGELMAS M, Zapata I, Tawil J, Pessetto A, et al
     Liver Cirrhosis Increases the Risk of Developing Advanced Colon Polyps.
     Dig Dis Sci. 2022 Jun 7. pii: 10.1007/s10620-022-07561.
     PubMed     Abstract available
     
     
     
121. NABI O, Boursier J, Lacombe K, Mathurin P, et al
     Comorbidities Are Associated with Fibrosis in NAFLD Subjects: A Nationwide Study (NASH-CO Study).
     Dig Dis Sci. 2022;67:2584-2593.
     PubMed     Abstract available
     
     
     May 2022
122. CLARK PJ, Valery PC, Strasser SI, Weltman M, et al
     Liver Disease and Poor Adherence Limit Hepatitis C Cure: A Real-World Australian Treatment Cohort.
     Dig Dis Sci. 2022 May 13. pii: 10.1007/s10620-022-07483.
     PubMed     Abstract available
     
     
     
123. ASOTIBE JC, Banini BA
     Hepatic Hydrothorax: An Independent Predictor of Mortality in Cirrhosis? Is the MELD-Na Score Worth Its Salt?
     Dig Dis Sci. 2022 May 9. pii: 10.1007/s10620-022-07523.
     PubMed    
     
     
     
124. OSMAN KT, Abdelfattah AM, Mahmood SK, Elkhabiry L, et al
     Refractory Hepatic Hydrothorax Is an Independent Predictor of Mortality When Compared to Refractory Ascites.
     Dig Dis Sci. 2022 May 9. pii: 10.1007/s10620-022-07522.
     PubMed     Abstract available
     
     
     April 2022
125. B HADI Y, Khan RS, Lakhani DA, Khan AY, et al
     Antibiotic Prophylaxis for Upper Gastrointestinal Bleed in Liver Cirrhosis; Less May Be More.
     Dig Dis Sci. 2022 Apr 25. pii: 10.1007/s10620-022-07481.
     PubMed     Abstract available
     
     
     
126. ZHAO M, Ma L, Honda T, Kato A, et al
     Astaxanthin Attenuates Nonalcoholic Steatohepatitis with Downregulation of Osteoprotegerin in Ovariectomized Mice Fed Choline-Deficient High-Fat Diet.
     Dig Dis Sci. 2022 Apr 10. pii: 10.1007/s10620-022-07489.
     PubMed     Abstract available
     
     
     
127. NOUREDDIN N, Noureddin M, Singh A, Alkhouri N, et al
     Progression of Nonalcoholic Fatty Liver Disease-Associated Fibrosis in a Large Cohort of Patients with Type 2 Diabetes.
     Dig Dis Sci. 2022;67:1379-1388.
     PubMed     Abstract available
     
     
     March 2022
128. BUCSICS T, Lampichler K, Vierziger C, Schoder M, et al
     Covered Transjugular Intrahepatic Portosystemic Shunt Improves Hypersplenism-Associated Cytopenia in Cirrhosis.
     Dig Dis Sci. 2022 Mar 17. pii: 10.1007/s10620-022-07443.
     PubMed     Abstract available
     
     
     
129. ANIEMEKA C, Pillai AA
     HCC Mortality Trends-In with ALD (and NAFLD) and Out with HCV.
     Dig Dis Sci. 2022 Mar 14. pii: 10.1007/s10620-022-07434.
     PubMed    
     
     
     
130. CHOI AY, Chang KJ, Samarasena JB, Lee JG, et al
     Endoscopic Ultrasound-Guided Porto-systemic Pressure Gradient Measurement Correlates with Histological Hepatic Fibrosis.
     Dig Dis Sci. 2022 Mar 12. pii: 10.1007/s10620-022-07418.
     PubMed     Abstract available
     
     
     
131. MAK LY, Wong DK, Cheung KS, Hui RW, et al
     Role of Serum M2BPGi Levels in Predicting Persistence of Advanced Fibrosis in Chronic Hepatitis B Virus Infection.
     Dig Dis Sci. 2022 Mar 8. pii: 10.1007/s10620-022-07429.
     PubMed     Abstract available
     
     
     
132. SAAB S, Pham N, Wu W, Dang L, et al
     Spontaneous Seroclearance Is Associated with Lower Liver Fibrosis in Treatment-Naive Chronic Hepatitis B Patients.
     Dig Dis Sci. 2022 Mar 4. pii: 10.1007/s10620-022-07402.
     PubMed     Abstract available
     
     
     February 2022
133. SINGH AD, Ford A, Lyu R, Layoun H, et al
     Impact of Cirrhotic Cardiomyopathy Diagnosed According to Different Criteria on Patients with Cirrhosis Awaiting Liver Transplantation: A Retrospective Cohort Study.
     Dig Dis Sci. 2022 Feb 12. pii: 10.1007/s10620-022-07412.
     PubMed     Abstract available
     
     
     
134. ROGAL SS, Chinman MJ, DeMonte W, Gibson S, et al
     Using Intervention Mapping to Develop a Novel Pain Self-Management Intervention for People with Cirrhosis.
     Dig Dis Sci. 2022 Feb 11. pii: 10.1007/s10620-022-07380.
     PubMed     Abstract available
     
     
     
135. SHENOY A, Louissaint J, Shannon C, Tapper EB, et al
     Viscoelastic Testing Prior to Non-surgical Procedures Reduces Blood Product Use Without Increasing Bleeding Risk in Cirrhosis.
     Dig Dis Sci. 2022 Feb 5. pii: 10.1007/s10620-021-07376.
     PubMed     Abstract available
     
     
     
136. JINDAL A, Sarin SK, Kumar M, Kumar G, et al
     Clinical Outcomes in Patients with Advanced Chronic Liver Disease and Hepatic Venous Pressure Gradient
     Dig Dis Sci. 2022 Feb 3. pii: 10.1007/s10620-021-07334.
     PubMed     Abstract available
     
     
     
137. GIBBS JT, Louissaint J, Tapper EB
     Rate of Successful Extubation in Mechanically Ventilated Patients with Cirrhosis and Hepatic Coma.
     Dig Dis Sci. 2022 Feb 2. pii: 10.1007/s10620-022-07400.
     PubMed     Abstract available
     
     
     January 2022
138. GONZALEZ JJ, Dziwis J, Patel YA, Tapper EB, et al
     Identifying Ascites in Patients with Cirrhosis Using Administrative Codes and Diuretic Use: A Multicenter Study.
     Dig Dis Sci. 2022 Jan 28. pii: 10.1007/s10620-021-07367.
     PubMed     Abstract available
     
     
     
139. PANCHAL SA, Kaplan DE, Goldberg DS, Mahmud N, et al
     Algorithms to Identify Alcoholic Hepatitis Hospitalizations in Patients with Cirrhosis.
     Dig Dis Sci. 2022 Jan 13. pii: 10.1007/s10620-021-07321.
     PubMed     Abstract available
     
     
     
140. CHANDAN S, Deliwala S, Khan SR, Ramai D, et al
     Advanced Endoscopic Resection Techniques in Cirrhosis-A Systematic Review and Meta-Analysis of Outcomes.
     Dig Dis Sci. 2022 Jan 6. pii: 10.1007/s10620-021-07364.
     PubMed     Abstract available
     
     
     
141. KHALIFA A, Sasso R, Rockey DC
     Role of Liver Biopsy in Assessment of Radiologically Identified Liver Masses.
     Dig Dis Sci. 2022;67:337-343.
     PubMed     Abstract available
     
     
     December 2021
142. HIGUERA-DE-LA-TIJERA F, Cordova-Gallardo J, Buganza-Torio E, Barranco-Fragoso B, et al
     Hepamet Fibrosis Score in Nonalcoholic Fatty Liver Disease Patients in Mexico: Lower than Expected Positive Predictive Value.
     Dig Dis Sci. 2021;66:4501-4507.
     PubMed     Abstract available
     
     
     November 2021
143. DONG TS, Jacobs JP, Agopian V, Pisegna JR, et al
     Duodenal Microbiome and Serum Metabolites Predict Hepatocellular Carcinoma in a Multicenter Cohort of Patients with Cirrhosis.
     Dig Dis Sci. 2021 Nov 20. pii: 10.1007/s10620-021-07299.
     PubMed     Abstract available
     
     
     
144. PODRUG K, Trkulja V, Zelenika M, Bokun T, et al
     Validation of the New Diagnostic Criteria for Clinically Significant Portal Hypertension by Platelets and Elastography.
     Dig Dis Sci. 2021 Nov 5. pii: 10.1007/s10620-021-07277.
     PubMed     Abstract available
     
     
     
145. BENITEZ C
     Pressure Measurements Under Pressure: Simplifying the Diagnosis of Clinically Significant Portal Hypertension.
     Dig Dis Sci. 2021 Nov 5. pii: 10.1007/s10620-021-07283.
     PubMed    
     
     
     
146. ABDU B, Akolkar S, Picking C, Boura J, et al
     Factors Associated with Delayed Paracentesis in Patients with Spontaneous Bacterial Peritonitis.
     Dig Dis Sci. 2021;66:4035-4045.
     PubMed     Abstract available
     
     
     October 2021
147. BURKHOLDER DA, Moran IJ, DiBattista JV, Lok AS, et al
     Accuracy of International Classification of Diseases-10 Codes for Cirrhosis and Portal Hypertensive Complications.
     Dig Dis Sci. 2021 Oct 21. pii: 10.1007/s10620-021-07282.
     PubMed     Abstract available
     
     
     September 2021
148. LI J, Lu M, Zhou Y, Bowlus CL, et al
     Dynamic Risk Prediction of Response to Ursodeoxycholic Acid Among Patients with Primary Biliary Cholangitis in the USA.
     Dig Dis Sci. 2021 Sep 9. pii: 10.1007/s10620-021-07219.
     PubMed     Abstract available
     
     
     
149. CHUN HS, Lee JS, Lee HW, Kim BK, et al
     Prevalence and Risk Factors of Cardiovascular Disease in Patients with Chronic Hepatitis B.
     Dig Dis Sci. 2021 Sep 2. pii: 10.1007/s10620-021-07157.
     PubMed     Abstract available
     
     
     
150. JEON Y, Limketkai BN
     Arrested Development: Slow Progression of Fibrosis in Patients with NAFLD and IBD.
     Dig Dis Sci. 2021;66:2853-2854.
     PubMed    
     
     
     August 2021
151. HANSEN L, Chang MF, Hiatt S, Dieckmann NF, et al
     Symptom Frequency and Distress Underestimated in Decompensated Cirrhosis.
     Dig Dis Sci. 2021 Aug 27. pii: 10.1007/s10620-021-07216.
     PubMed     Abstract available
     
     
     
152. TRIVEDI HD, Niezen S, Jiang ZG, Tapper EB, et al
     Severe Hepatic Steatosis by Controlled Attenuation Parameter Predicts Quality of Life Independent of Fibrosis.
     Dig Dis Sci. 2021 Aug 21. pii: 10.1007/s10620-021-07228.
     PubMed     Abstract available
     
     
     
153. VIJAYARAGHAVAN R, Maiwall R, Arora V, Choudhary A, et al
     Reversal of Feed Intolerance by Prokinetics Improves Survival in Critically Ill Cirrhosis Patients.
     Dig Dis Sci. 2021 Aug 14. pii: 10.1007/s10620-021-07185.
     PubMed     Abstract available
     
     
     
154. ZHANG S, Tao X, Wang L, Chen H, et al
     Downregulation of Programmed Death-1 Pathway Promoting CD8 + T Cell Cytotoxicity in Primary Biliary Cholangitis.
     Dig Dis Sci. 2021 Aug 14. pii: 10.1007/s10620-021-07165.
     PubMed     Abstract available
     
     
     
155. THAKER S, Mikolajczyk AE
     Concise Commentary: Are We Making a Difference? The Impact of Inpatient Gastroenterology and Hepatology Consultations for Cirrhotic Patients.
     Dig Dis Sci. 2021 Aug 10. pii: 10.1007/s10620-021-07171.
     PubMed    
     
     
     
156. SERPER M, Kaplan DE, Lin M, Taddei TH, et al
     Inpatient Gastroenterology Consultation and Outcomes of Cirrhosis-Related Hospitalizations in Two Large National Cohorts.
     Dig Dis Sci. 2021 Aug 10. pii: 10.1007/s10620-021-07150.
     PubMed     Abstract available
     
     
     July 2021
157. CULLARO G, Rubin JB, Fortune BE, Crawford CV, et al
     Association Between Kidney Dysfunction Types and Mortality Among Hospitalized Patients with Cirrhosis.
     Dig Dis Sci. 2021 Jul 22. pii: 10.1007/s10620-021-07159.
     PubMed     Abstract available
     
     
     
158. HAI Y, Chong W, Eisenbrey JR, Forsberg F, et al
     Network Meta-Analysis: Noninvasive Imaging Modalities for Identifying Clinically Significant Portal Hypertension.
     Dig Dis Sci. 2021 Jul 17. pii: 10.1007/s10620-021-07168.
     PubMed     Abstract available
     
     
     
159. BOPPANA V, Sahni S, Glass J, Chang C, et al
     HCC You Cannot See.
     Dig Dis Sci. 2021;66:2185-2189.
     PubMed    
     
     
     June 2021
160. DELEURAN T, Watson H, Vilstrup H, Jepsen P, et al
     Risk Factors for Hepatic Hydrothorax in Cirrhosis Patients with Ascites - A Clinical Cohort Study.
     Dig Dis Sci. 2021 Jun 30. pii: 10.1007/s10620-021-07134.
     PubMed     Abstract available
     
     
     
161. CANCADO GGL, Braga MH, Ferraz MLG, Villela-Nogueira CA, et al
     Anti-mitochondrial Antibody-Negative Primary Biliary Cholangitis Is Part of the Same Spectrum of Classical Primary Biliary Cholangitis.
     Dig Dis Sci. 2021 Jun 28. pii: 10.1007/s10620-021-07122.
     PubMed     Abstract available
     
     
     
162. ZHOU K, Dodge JL, Yuan L, Terrault NA, et al
     Metabolic Risk Profiles for Hepatic Steatosis Differ by Race/Ethnicity: An Elastography-Based Study of US Adults.
     Dig Dis Sci. 2021 Jun 26. pii: 10.1007/s10620-021-07124.
     PubMed     Abstract available
     
     
     
163. FRENETTE CT, Levy C, Saab S
     Hepatic Encephalopathy-Related Hospitalizations in Cirrhosis: Transition of Care and Closing the Revolving Door.
     Dig Dis Sci. 2021 Jun 24. pii: 10.1007/s10620-021-07075.
     PubMed     Abstract available
     
     
     
164. GELOW K, Chalasani S, Green K, Lammert C, et al
     Utilization and Impact of Complementary and Alternative Medicines in Symptomatic Autoimmune Hepatitis Patients.
     Dig Dis Sci. 2021 Jun 23. pii: 10.1007/s10620-021-07112.
     PubMed     Abstract available
     
     
     
165. HA NB, Cho SJ, Mohamad Y, Kent D, et al
     Visceral Adipose Tissue Inflammation and Radiographic Visceral-to-Subcutaneous Adipose Tissue Ratio in Patients with Cirrhosis.
     Dig Dis Sci. 2021 Jun 16. pii: 10.1007/s10620-021-07099.
     PubMed     Abstract available
     
     
     
166. DAHIYA M, Eboreime E, Hyde A, Rahman S, et al
     International Classification of Diseases Codes are Useful in Identifying Cirrhosis in Administrative Databases.
     Dig Dis Sci. 2021 Jun 6. pii: 10.1007/s10620-021-07076.
     PubMed     Abstract available
     
     
     May 2021
167. PENG X, Tian A, Li J, Mao Y, et al
     Diagnostic Value of FibroTouch and Non-invasive Fibrosis Indexes in Hepatic Fibrosis with Different Aetiologies.
     Dig Dis Sci. 2021 May 31. pii: 10.1007/s10620-021-07049.
     PubMed     Abstract available
     
     
     
168. CACCAMO G, Franze MS, Saffioti F, Pitrone C, et al
     Cirrhotic Patients with Bacterial Infection and Negative Cultures Have a More Advanced Disease and an Increased Short-Term Mortality Rate.
     Dig Dis Sci. 2021 May 26. pii: 10.1007/s10620-021-07047.
     PubMed     Abstract available
     
     
     
169. PINYOPORNPANISH K, Al-Yaman W, Dasarathy S, Romero-Marrero C, et al
     Hepatocellular Carcinoma in Patients Without Cirrhosis: The Fibrosis Stage Distribution, Characteristics and Survival.
     Dig Dis Sci. 2021 May 23. pii: 10.1007/s10620-021-07048.
     PubMed     Abstract available
     
     
     
170. SERPER M
     Monitoring for Ascites in Cirrhosis Using Patient-Generated Health Data: No Longer a Remote Possibility.
     Dig Dis Sci. 2021 May 18. pii: 10.1007/s10620-021-07020.
     PubMed    
     
     
     
171. LIN MH, Li HQ, Zhu L, Su HY, et al
     Liver Fibrosis in the Natural Course of Chronic Hepatitis B Viral Infection: A Systematic Review with Meta-Analysis.
     Dig Dis Sci. 2021 May 18. pii: 10.1007/s10620-021-07009.
     PubMed     Abstract available
     
     
     
172. BLOOM PP, Ventoso M, Tapper E, Ha J, et al
     A Telemonitoring Intervention for Cirrhotic Ascites Management Is Cost-Saving.
     Dig Dis Sci. 2021 May 6. pii: 10.1007/s10620-021-07013.
     PubMed     Abstract available
     
     
     April 2021
173. TROWELL J, Alukal J, Zhang T, Liu L, et al
     How Good Are Controlled Attenuation Parameter Scores from Fibroscan to Assess Steatosis, NASH, and Fibrosis?
     Dig Dis Sci. 2021;66:1297-1305.
     PubMed     Abstract available
     
     
     March 2021
174. MAHMUD N, Asrani SK, Reese PP, Kaplan DE, et al
     Race Adjustment in eGFR Equations Does Not Improve Estimation of Acute Kidney Injury Events in Patients with Cirrhosis.
     Dig Dis Sci. 2021 Mar 24. pii: 10.1007/s10620-021-06943.
     PubMed     Abstract available
     
     
     February 2021
175. JONES BE, Allegretti AS, Pose E, Mara KC, et al
     Renal Replacement Therapy for Acute Kidney Injury in Severe Alcohol-Associated Hepatitis as a Bridge to Transplant or Recovery.
     Dig Dis Sci. 2021 Feb 19. pii: 10.1007/s10620-021-06864.
     PubMed     Abstract available
     
     
     
176. CHEN YC, Hsu CW, Jeng WJ, Lin CY, et al
     Advanced Liver Fibrosis Is Associated with Necroinflammatory Grade but Not Hepatic Steatosis in Chronic Hepatitis B Patients.
     Dig Dis Sci. 2021 Feb 10. pii: 10.1007/s10620-020-06761.
     PubMed     Abstract available
     
     
     January 2021
177. BALDIN C, Piedade J, Guimaraes L, Victor L, et al
     CLIF-C AD Score Predicts Development of Acute Decompensations and Survival in Hospitalized Cirrhotic Patients.
     Dig Dis Sci. 2021 Jan 3. pii: 10.1007/s10620-020-06791.
     PubMed     Abstract available
     
     
     
178. HSU CY, Parikh ND, Huo TI, Tapper EB, et al
     Comparison of Seven Noninvasive Models for Predicting Decompensation and Hospitalization in Patients with Cirrhosis.
     Dig Dis Sci. 2021 Jan 2. pii: 10.1007/s10620-020-06763.
     PubMed     Abstract available
     
     
     November 2020
179. O'LEARY JG, Rajender Reddy K, Tandon P, Biggins SW, et al
     Increased Risk of ACLF and Inpatient Mortality in Hospitalized Patients with Cirrhosis and Hepatic Hydrothorax.
     Dig Dis Sci. 2020 Nov 13. pii: 10.1007/s10620-020-06677.
     PubMed     Abstract available
     
     
     
180. NAYMAGON L, Tremblay D, Zubizarreta N, Moshier E, et al
     Safety, Efficacy, and Long-Term Outcomes of Anticoagulation in Cirrhotic Portal Vein Thrombosis.
     Dig Dis Sci. 2020 Nov 5. pii: 10.1007/s10620-020-06695.
     PubMed     Abstract available
     
     
     
181. ABY ES, Pham NV, Yum JJ, Dong TS, et al
     Frailty Does Not Impact Caregiver Burden in Patients with Cirrhosis.
     Dig Dis Sci. 2020 Nov 2. pii: 10.1007/s10620-020-06687.
     PubMed     Abstract available
     
     
     
182. CHEN HW, Ferrando A, White MG, Dennis RA, et al
     Home-Based Physical Activity and Diet Intervention to Improve Physical Function in Advanced Liver Disease: A Randomized Pilot Trial.
     Dig Dis Sci. 2020;65:3350-3359.
     PubMed     Abstract available
     
     
     October 2020
183. MUNOZ AE, Pollarsky F, Marino M, Cartier M, et al
     Safety of Chronic Simvastatin Treatment in Patients with Decompensated Cirrhosis: Many Adverse Events but No Liver Injury.
     Dig Dis Sci. 2020 Oct 9. pii: 10.1007/s10620-020-06630.
     PubMed     Abstract available
     
     
     September 2020
184. PATEL YA, Yao J, Proeschold-Bell RJ, Niedzwiecki D, et al
     Reduced Alcohol Use Is Sustained in Patients Provided Alcohol-Related Counseling During Direct-Acting Antiviral Therapy for Hepatitis C.
     Dig Dis Sci. 2020 Sep 23. pii: 10.1007/s10620-020-06616.
     PubMed     Abstract available
     
     
     
185. RITACCIO G, Stoleru G, Abutaleb A, Cross RK, et al
     Nonalcoholic Fatty Liver Disease Is Common in IBD Patients However Progression to Hepatic Fibrosis by Noninvasive Markers Is Rare.
     Dig Dis Sci. 2020 Sep 7. pii: 10.1007/s10620-020-06588.
     PubMed     Abstract available
     
     
     
186. PATEL A, Asch S, Antonio AL, Kanwal F, et al
     Measuring the Quality of Palliative Care for Patients with End-Stage Liver Disease.
     Dig Dis Sci. 2020;65:2562-2570.
     PubMed     Abstract available
     
     
     August 2020
187. DENG LX, Mehta N
     Does Hepatocellular Carcinoma Surveillance Increase Survival in At-Risk Populations? Patient Selection, Biomarkers, and Barriers.
     Dig Dis Sci. 2020 Aug 29. pii: 10.1007/s10620-020-06550.
     PubMed     Abstract available
     
     
     
188. PHAW NA, Dyson JK, Mells G, Jones D, et al
     Understanding Fatigue in Primary Biliary Cholangitis.
     Dig Dis Sci. 2020 Aug 26. pii: 10.1007/s10620-020-06502.
     PubMed     Abstract available
     
     
     
189. PALERMO A, Gerussi A, Mulinacci G, Invernizzi P, et al
     Identifying Racial Disparities in Primary Biliary Cholangitis Patients: A Step Toward Achieving Equitable Outcomes Among All.
     Dig Dis Sci. 2020 Aug 13. pii: 10.1007/s10620-020-06528.
     PubMed    
     
     
     
190. FONG TL, Lee BT, Chang M, Nasanbayar K, et al
     High Prevalence of Chronic Viral Hepatitis and Liver Fibrosis Among Mongols in Southern California.
     Dig Dis Sci. 2020 Aug 8. pii: 10.1007/s10620-020-06499.
     PubMed     Abstract available
     
     
     
191. GRUTTADAURIA S, Pagano D, di Francesco F, Foglio A, et al
     Adult to Adult Living Donor Liver Transplantation in Recipients with Low MELD: A Strategy Intended to Overcome Donor Shortage.
     Dig Dis Sci. 2020 Aug 5. pii: 10.1007/s10620-020-06522.
     PubMed     Abstract available
     
     
     
192. BALAKRISHNAN M, Seth A, Cortes-Santiago N, Jain S, et al
     External Validation of Four Point-of-Care Noninvasive Scores for Predicting Advanced Hepatic Fibrosis in a Predominantly Hispanic NAFLD Population.
     Dig Dis Sci. 2020 Aug 5. pii: 10.1007/s10620-020-06501.
     PubMed     Abstract available
     
     
     
193. NATARAJAN Y, Tansel A, Patel P, Emologu K, et al
     Incidence of Hepatocellular Carcinoma in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis.
     Dig Dis Sci. 2020 Aug 2. pii: 10.1007/s10620-020-06498.
     PubMed     Abstract available
     
     
     July 2020
194. LE L, Kullar R, Saleh HM, Saab S, et al
     Preferred Noninvasive Testing for Nonalcoholic Steatohepatitis.
     Dig Dis Sci. 2020 Jul 15. pii: 10.1007/s10620-020-06382.
     PubMed     Abstract available
     
     
     
195. XIE X, Dou CY, Zhou Y, Zhou Q, et al
     MicroRNA-503 Targets Mothers Against Decapentaplegic Homolog 7 Enhancing Hepatic Stellate Cell Activation and Hepatic Fibrosis.
     Dig Dis Sci. 2020 Jul 9. pii: 10.1007/s10620-020-06460.
     PubMed     Abstract available
     
     
     June 2020
196. ADEJUMO AC, Akhtar DH, Dennis BB, Cholankeril G, et al
     Gender and Racial Differences in Hospitalizations for Primary Biliary Cholangitis in the USA.
     Dig Dis Sci. 2020 Jun 13. pii: 10.1007/s10620-020-06402.
     PubMed     Abstract available
     
     
     May 2020
197. SHROFF H, Rinella ME
     Thanks to CLD for Small Favors: Reduced CVD Risk in Patients Awaiting Liver Transplantation.
     Dig Dis Sci. 2020 May 29. pii: 10.1007/s10620-020-06322.
     PubMed    
     
     
     April 2020
198. ACHARYA C, White MB, Fagan A, Sterling RK, et al
     Liver Transplant Is Associated with Sustained Improvement in Tandem Gait and Risk of Falls.
     Dig Dis Sci. 2020 Apr 22. pii: 10.1007/s10620-020-06261.
     PubMed     Abstract available
     
     
     
199. TESTINO G
     Transjugular Intrahepatic Porto Systemic Shunt for Hepatorenal Syndrome in Alcoholic Patients.
     Dig Dis Sci. 2020 Apr 13. pii: 10.1007/s10620-020-06243.
     PubMed    
     
     
     
200. O'BEIRNE J
     Liver Transplantation for Alcoholic Liver Disease: Absence of Evidence for the Relevance of Abstinence.
     Dig Dis Sci. 2020 Apr 3. pii: 10.1007/s10620-020-06235.
     PubMed    
     
     
     March 2020
201. LI J, Dong S, Ye M, Peng G, et al
     MicroRNA-489-3p Represses Hepatic Stellate Cells Activation by Negatively Regulating the JAG1/Notch3 Signaling Pathway.
     Dig Dis Sci. 2020 Mar 7. pii: 10.1007/s10620-020-06174.
     PubMed     Abstract available
     
     
     February 2020
202. MELLINGER JL, Stine JG
     Early Liver Transplantation for Severe Alcoholic Hepatitis.
     Dig Dis Sci. 2020 Feb 27. pii: 10.1007/s10620-020-06159.
     PubMed     Abstract available
     
     
     
203. AMJAD W, Alukal J, Doycheva I, Zhang T, et al
     A Combination of N-Acetylcysteine and Prednisone Has No Benefit Over Prednisone Alone in Severe Alcoholic Hepatitis: A Retrospective Analysis.
     Dig Dis Sci. 2020 Feb 18. pii: 10.1007/s10620-020-06142.
     PubMed     Abstract available
     
     
     January 2020
204. CHIANG RS, Parish A, Niedzwiecki D, Kappus MR, et al
     Impact of Malnutrition on Outcomes in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt Insertion.
     Dig Dis Sci. 2020 Jan 21. pii: 10.1007/s10620-019-06038.
     PubMed     Abstract available
     
     
     
205. ENOMOTO M, Kawada N
     The Moral of Hepatic Fibrosis: Don't Always Believe Noninvasive Fibrosis Measurements.
     Dig Dis Sci. 2020 Jan 1. pii: 10.1007/s10620-019-06035.
     PubMed    
     
     
     December 2019
206. UNGER LW, Forstner B, Muckenhuber M, Scheuba K, et al
     Hepatic Steatosis in Lean Patients: Risk Factors and Impact on Mortality.
     Dig Dis Sci. 2019 Dec 24. pii: 10.1007/s10620-019-06000.
     PubMed     Abstract available
     
     
     
207. KAPS L, Grambihler A, Yemane B, Nagel M, et al
     Symptom Burden and Treatment Response in Patients with Primary Biliary Cholangitis (PBC).
     Dig Dis Sci. 2019 Dec 18. pii: 10.1007/s10620-019-06009.
     PubMed     Abstract available
     
     
     November 2019
208. CHEN Y, Ji H, Shao J, Jia Y, et al
     Different Hepatitis C Virus Infection Statuses Show a Significant Risk of Developing Type 2 Diabetes Mellitus: A Network Meta-Analysis.
     Dig Dis Sci. 2019 Nov 23. pii: 10.1007/s10620-019-05918.
     PubMed     Abstract available
     
     
     
209. HSU PY, Hsu CT, Yeh ML, Huang CF, et al
     Early Fibrosis but Late Tumor Stage and Worse Outcomes in Hepatocellular Carcinoma Patients Without Hepatitis B or Hepatitis C.
     Dig Dis Sci. 2019 Nov 13. pii: 10.1007/s10620-019-05938.
     PubMed     Abstract available
     
     
     October 2019
210. HUANG R, Rao H, Yang M, Gao Y, et al
     Noninvasive Measurements Predict Liver Fibrosis Well in Hepatitis C Virus Patients After Direct-Acting Antiviral Therapy.
     Dig Dis Sci. 2019 Oct 25. pii: 10.1007/s10620-019-05886.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Liver Cirrhosis is free of charge.